Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacillus clausii vs Saccharomyces boulardii in pediatric acute watery diarrhea
NCT06540209Completed
- Sponsor
- RESnTEC (Research and Technology) Ltd
- Start
- Apr 2023
- Primary completion
- Sep 2023
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
Randomised trial of bacillus clausii and saccharomyces boulardii in acute watery diarrhea, sponsored by RESnTEC (Research and Technology) Ltd. Primary endpoint: Stool frequency at 5 days. Started Apr 2023; status: completed.
02
Drugs
bacillus clausiisaccharomyces boulardii
03
Conditions
acute watery diarrhea
Beyond the preview
Go deeper on NCT06540209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06540209.